03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Early in 2019, social media feeds, from Instagram to Twitter and Facebook, were filled with “10-Yea...
Read More >
After months of drama that we dutifully catalogued right here, the U.S. plan to “force the sale of ...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Assignment Earth which aired...
Read More >
As the evolving coronavirus virus (COVID-19) first discovered in China continues to grow in both Chi...
Read More >
2020 is on the horizon, and employers must be ready to comply with many new developments in the worl...
Read More >
In Maude v NOV Enerflow ULC, 2019 AHRC 54, the Human Rights Tribunal of Alberta provided some helpfu...
Read More >